Pariglasgene brecaparvovec
DTX401-CL401
Approved small_molecule active
Quick answer
Pariglasgene brecaparvovec for Glycogen storage disease type Ia (GSDIa) is a Approved program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Glycogen storage disease type Ia (GSDIa)
- Phase
- Approved
- Modality
- small_molecule
- Status
- active